Stay updated on Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedClinicalTrials.gov’s page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than study-specific content changes.SummaryDifference0.1%

- Check26 days agoChange DetectedThe page revision tag was updated from v3.5.0 to v3.5.2. This change does not affect the study content or user interactions.SummaryDifference0.1%

- Check55 days agoChange DetectedUpdated page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.4.3 added and v3.4.2 removed. No other visible content changes are shown.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision: v3.4.2 added and older maintenance notices (including the v3.4.1 revision and a funding-status notice) removed; no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check98 days agoChange DetectedAdded a site-wide notice about a lapse in government funding informing users that updates may not be up to date and providing status of the NIH Clinical Center, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.